GPR183‐mediated activation of PI3K is a potential biomarker for immunotherapy in lung cancer.
Saved in:
| Title: | GPR183‐mediated activation of PI3K is a potential biomarker for immunotherapy in lung cancer. |
|---|---|
| Authors: | Ye, Ling1 (AUTHOR), Zheng, Nannan1,2 (AUTHOR), Liu, Fangming3 (AUTHOR), Fu, Huirong1,4 (AUTHOR), Liu, Yifei5 (AUTHOR), Yang, Ying6 (AUTHOR), Qi, Ruixue6 (AUTHOR), Wu, Duojiao6,7 (AUTHOR), Shi, Lin1 (AUTHOR) linshi0124@126.com, Song, Dongli1,3,7 (AUTHOR) songdongli37@126.com |
| Source: | Clinical & Translational Discovery. Feb2026, Vol. 6 Issue 1, p1-16. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 192088068 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: GPR183‐mediated activation of PI3K is a potential biomarker for immunotherapy in lung cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Ye%2C+Ling%22">Ye, Ling</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zheng%2C+Nannan%22">Zheng, Nannan</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Fangming%22">Liu, Fangming</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fu%2C+Huirong%22">Fu, Huirong</searchLink><relatesTo>1,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Yifei%22">Liu, Yifei</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yang%2C+Ying%22">Yang, Ying</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Qi%2C+Ruixue%22">Qi, Ruixue</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wu%2C+Duojiao%22">Wu, Duojiao</searchLink><relatesTo>6,7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shi%2C+Lin%22">Shi, Lin</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> linshi0124@126.com</i><br /><searchLink fieldCode="AR" term="%22Song%2C+Dongli%22">Song, Dongli</searchLink><relatesTo>1,3,7</relatesTo> (AUTHOR)<i> songdongli37@126.com</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Clinical+%26+Translational+Discovery%22">Clinical & Translational Discovery</searchLink>. Feb2026, Vol. 6 Issue 1, p1-16. 16p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=192088068 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/ctd2.70119 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 16 StartPage: 1 Titles: – TitleFull: GPR183‐mediated activation of PI3K is a potential biomarker for immunotherapy in lung cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ye, Ling – PersonEntity: Name: NameFull: Zheng, Nannan – PersonEntity: Name: NameFull: Liu, Fangming – PersonEntity: Name: NameFull: Fu, Huirong – PersonEntity: Name: NameFull: Liu, Yifei – PersonEntity: Name: NameFull: Yang, Ying – PersonEntity: Name: NameFull: Qi, Ruixue – PersonEntity: Name: NameFull: Wu, Duojiao – PersonEntity: Name: NameFull: Shi, Lin – PersonEntity: Name: NameFull: Song, Dongli IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: Feb2026 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 27680622 Numbering: – Type: volume Value: 6 – Type: issue Value: 1 Titles: – TitleFull: Clinical & Translational Discovery Type: main |
| ResultId | 1 |